Embed Size (px)
Citation preview
Radiotherapy Research Seminar Series
Why are we offering this and why would you wish to attend?
Topic: Organ Preservation for Rectal Cancer: the dawn of new approaches
Speaker: Professor David Sebag-Montefiore, Consultant Clinical Oncologist St James’s University Hospital LeedsDate: Friday 5th February 2016, 8.30 for coffee(F514) 9am startVenue: F518 Robert Winston Building.
Who is this session for?This is relevant to practitioners working in Radiotherapy and Oncology but we welcome attendance from anyone with an
interest in the topic area or an interest in research. If you would like to attend please contact Jo Doughty
Sessions are outside formal conference attendance, see leading professionals in your field present their research experiences
Ask questions and discuss topics with colleagues, sharing your experiences with staff and students who attend the seminars
Free CPD activity
Staff have previously commented...
“These seminar series are invaluable. It's really informative and useful for radiotherapy students to actually see what trials and studies are being done
currently, and how this may impact on future clinical practice. Also, useful for our own studies”
AND
“Excellent and very interesting and enjoyable. Extremely well explained concepts and insight into related research”
This seminar session will give participants an insight into emerging evidence of new approaches to the non surgical management of rectal cancer – rather than radical surgery can patients avoid or delay radical surgery?
Professor David Sebag-MontefioreDavid Sebag-Montefiore is the Audrey and Stanley Burton Professor of Clinical Oncology at the University of Leeds and Honorary Consultant at Leeds Cancer Centre.
His research interests include clinical trials and radiotherapy research with a focus on gastrointestinal cancers. He is the Chief Investigator of the CR07 and ARISTOTLE trials and co-lead for the ACT2, STAR TREC and PLATO trials. He is a member of the NCRI Colorectal study group, its anorectal subgroup and is Vice Chair of the NCRI CTRad group. He was Chair of Cancer Research UK’s Clinical Trial Awards and Advisory Committee 2011-2014.
He has over 80 peer reviewed publications including high impact outputs in Lancet, Lancet Oncology and JCO. He teaches on the Sheffield Part II FRCR course and at the European School of Oncology Masterclasses. He leads the Leeds Radiotherapy Research Group focusing on radiotherapy research that improves patient outcomes.
